Transtema Q4 2022: Strong Growth and Healthy Margins - Redeye

Redeye strengthens its positive view of Transtema following its Q4 report. The strong organic growth is the quarter’s highlight, and together with the healthy EBITA margin, the EBITA was significantly better than expected. Q4 shows that Transtema handles the inflationary environment well, at least so far. We will likely increase our Base Case and Forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/875202/transtema-q4-2022-strong-growth-and-healthy-margins?utm_source=finwire&utm_medium=RSS